文献速递中医妇科中药与中成药合理使用

桂枝茯苓丸治疗子宫内膜异位症的潜在机制:基于TCMSP与DisGeNET数据库的分析

Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases.
PubMed 文献 · J Ethnopharmacol · 2024-04-16

本文综述了桂枝茯苓丸(GFW)治疗子宫内膜异位症的潜在机制。通过文献回顾5项临床前研究和13项临床研究,并结合TCMSP与DisGeNET数据库的网络分析,发现GFW可能通过调节免疫、凋亡和血管生成相关因子抑制异位病灶生长,并增强西药疗效;通路分析提示其作用主要涉及AGE-RAGE、Kaposi肉瘤相关疱疹病毒感染、人巨细胞病毒感染及流体剪切应力与动脉粥样硬化等通路。

要点

  • 桂枝茯苓丸可能通过调节免疫、凋亡和血管生成抑制子宫内膜异位病灶。
  • GFW可增强西药治疗子宫内膜异位症的疗效。
  • 网络分析提示AGE-RAGE等炎症、血管生成和凋亡相关通路是关键机制。

核心结论

  • 子宫内膜异位症与异常炎症、血管生成和凋亡活动高度相关,桂枝茯苓丸的治疗作用可能通过调节这些活动实现。

研究设计与样本

  • 本文为综述,检索PubMed、Science Direct和CNKI中关于桂枝茯苓丸与子宫内膜异位症的文献,纳入5项临床前研究和13项临床研究。
  • 同时从TCMSP数据库提取各味中药的靶分子,从DisGeNET获取子宫内膜异位症相关基因,并利用David Bioinformatics Resources进行通路和基因本体分析。

主要发现

  • 临床前和临床研究表明,GFW可能通过调节免疫、凋亡调节分子和血管生成相关因子抑制异位病灶生长,并增强西药治疗子宫内膜异位症的疗效。
  • 通路和基因本体分析显示,GFW可能主要通过影响糖尿病并发症中的AGE-RAGE信号通路(hsa04933)以及Kaposi肉瘤相关疱疹病毒感染(hsa05167)、人巨细胞病毒感染(has05163)、流体剪切应力与动脉粥样硬化(hsa05418)等通路减轻疾病。
  • 上述通路均涉及炎症、血管生成和凋亡的调节,且被所有组成中药共同影响。

关键数值与推荐

  • 纳入5项临床前研究和13项临床研究进行综述。
  • 关键通路包括AGE-RAGE信号通路(hsa04933)、Kaposi肉瘤相关疱疹病毒感染(hsa05167)、人巨细胞病毒感染(has05163)、流体剪切应力与动脉粥样硬化(hsa05418)。

临床怎么用

  • 对于子宫内膜异位症患者,可考虑在辨证基础上使用桂枝茯苓丸,或与西药联用以增强疗效。
  • 临床运用时可关注其调节炎症、血管生成和凋亡的潜在作用,但需结合患者具体证候。

局限性

  • 本文为综述,证据主要来自临床前研究和临床研究的汇总,缺乏大规模随机对照试验的直接验证。
  • 网络分析结果基于数据库预测,需进一步实验研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Guizhi Fuling Wan (GFW), is a traditional Chinese herbal formula that consists of Cinnamomi Ramulus (Guizhi), Poria Cocos(Schw.) Wolf. (Fuling), Persicae Semen (Taoren), Radix Paeoniae Rubra (Chishao), and Cortex Moutan (Mudanpi). This formula has been used in traditional Chinese medicine for more than 1800 years to treat disorders caused by stagnation of circulation and qi (air). AIM OF THE STUDY: Based on pre-clinical and clinical studies, this review aimed to reveal the potential mechanisms of GFW in inhibiting endometriosis. The enhancement of therapeutic effects of western medications on endometriosis by GFW was also shown. MATERIALS AND METHODS: A bibliographic assessment of publications on "Guizhi Fuling Wan" and "endometriosis" indexed in PubMed, Science Direct, and China National Knowledge Infrastructure (CNKI) was conducted. Five pre-clinical studies and 13 clinical studies were selected for this review. Moreover, the targeted molecules of each herb were first extracted from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) Database and Analysis Platform followed by obtaining the endometriosis-related genes from DisGeNET. Subsequently, pathway and gene ontology analyses using David Bioinformatics Resources explored the potential mechanisms of therapeutic effects of GFW in treating endometriosis. RESULTS: Pre-clinical and clinical studies showed that GFW might inhibit the growth of endometriotic lesion through the modulation of immunity, apoptosis-regulating molecules, and angiogenesis-associated factors, while enhancing the therapeutic effects of western medications in treating endometriosis. Furthermore, pathway and gene ontology analyses demonstrated that GFW might attenuate the disease primarily by affecting AGE-RAGE signaling pathway in diabetic complications (hsa04933) as well as pathways involved in Kaposi sarcoma-associated herpesvirus infection (hsa05167), human cytomegalovirus infection (has05163), and fluid shear stress and atherosclerosis (hsa05418). These pathways were all involved in the regulation of inflammation, angiogenesis, and apoptosis and commonly affected by all herbs. CONCLUSIONS: The current review revealed that endometriosis is highly associated with aberrant inflammatory, angiogenic, and apoptotic activities. The therapeutic effects of GFW on endometriosis are likely to act through regulating these activities.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Yee JL, Huang CY, Yu YC, et al. Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases. J Ethnopharmacol. 2024. PMID: 38614264. doi:10.1016/j.jep.2024.118190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。